# Relmada Therapeutics, Inc.: Form 8-K, filed Jun 15, 2017

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2017-06-15
- Accepted by EDGAR: Jun 15, 2017, 16:30 ET
- Period: 2017-06-12
- Accession: 0001213900-17-006520
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390017006520/f8k061517b_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390017006520/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390017006520/f8k061517b_relmada.htm

Filed Jun 15, 2017.
Source: SEC EDGAR, the filing index for accession 0001213900-17-006520. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
